Potential treatment of Alzheimer’s disease astrocyte pathology based on nuclear lipid regulation

Bibliographic Details
Published in:	Neural Regeneration Research
Main Authors:	Masato Komai, Nobumasa Takasugi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-01-01
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01125

Similar Items

Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes
by: Masato Komai, et al.
Published: (2024-03-01)

The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
by: Nobumasa Takasugi, et al.
Published: (2023-01-01)

Pathological phenotypes of astrocytes in Alzheimer’s disease
by: Junhyung Kim, et al.
Published: (2024-01-01)

Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways
by: Pranav Preman, et al.
Published: (2021-03-01)

Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
by: Hannah Chew, et al.
Published: (2020-06-01)

CO-CULTURES BETWEEN NEURONS AND ASTROCYTES TO ADDRESS ALZHEIMER´S DISEASE PATHOLOGY
by: Laura Cáceres Palomo, et al.
Published: (2023-10-01)

Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer’s Disease
by: Livia La Barbera, et al.
Published: (2025-10-01)

Astrocytic functions and lipid metabolism: Correlations and therapeutic targets in Alzheimer's disease and glioblastoma
by: Xu Zhang, et al.
Published: (2024-04-01)

Polar lipids modify Alzheimer’s Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation
by: Sakshi Hans, et al.
Published: (2024-04-01)

Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology
by: Yee Fun Lee, et al.
Published: (2023-08-01)

Optogenetics in Alzheimer’s Disease: Focus on Astrocytes
by: Elena Mitroshina, et al.
Published: (2023-10-01)

The Many Faces of Astrocytes in Alzheimer's Disease
by: Michael D. Monterey, et al.
Published: (2021-08-01)

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
by: Minna Oksanen, et al.
Published: (2017-12-01)

Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease
by: Francheska Delgado-Peraza, et al.
Published: (2021-04-01)

Upregulation of astrocytic α7 nicotinic receptors in Alzheimer's disease brain- possible relevant to amyloid pathology
by: Yu Wenfeng, et al.
Published: (2012-02-01)

Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART‐MR Study
by: Emma L. Twait, et al.
Published: (2024-02-01)

The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease
by: Jialin Han, et al.
Published: (2025-05-01)

Research progress of astrocyte phagocytosis in Alzheimer′s disease
by: QIN Xiaoli, ZHAO Linna, FU Rong, GUO Yuying, XU Shixin
Published: (2024-08-01)

Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
by: Rebecca M. Fleeman, et al.
Published: (2021-03-01)

Neuron-astrocyte transmitophagy is altered in Alzheimer's disease
by: Riikka Lampinen, et al.
Published: (2022-08-01)

Astrocyte Senescence and Alzheimer’s Disease: A Review
by: Xiaojuan Han, et al.
Published: (2020-06-01)

Pathologic Potential of Astrocytic Vesicle Traffic: New Targets to Treat Neurologic Diseases?
by: Nina Vardjan, et al.
Published: (2015-04-01)

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
by: Julia TCW, et al.
Published: (2023-03-01)

Pathology and Astrocytes in Autism
by: Vakilzadeh G, et al.
Published: (2023-04-01)

Cerebrospinal fluid neuronal pentraxin levels are associated with tau pathology via microglia–astrocyte signaling in alzheimer’s disease
by: Zihao Zhang, et al.
Published: (2025-10-01)

Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
by: Zehu Sheng, et al.
Published: (2025-01-01)

Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology
by: Grégoire Stym-Popper, et al.
Published: (2023-03-01)

Mass Spectrometry-Based Analysis of Lipid Involvement in Alzheimer’s Disease Pathology—A Review
by: Andrea R. Kelley
Published: (2022-06-01)

Prevention and Treatment Strategies for Alzheimer’s Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
by: Zhang S, et al.
Published: (2024-10-01)

POTENTIAL ROLE OF THE INTESTINAL MICROBIOTA IN ALZHEIMER’S DISEASE PROGRESSION, SCFA EFFECTS ON ASTROCYTIC CULTURES.
by: Pablo Miaja Hernandez, et al.
Published: (2023-10-01)

Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
by: Miguel Moutinho, et al.
Published: (2017-10-01)

The role of astrocytes in Alzheimer’s disease: a bibliometric analysis
by: Xiaoqiong An, et al.
Published: (2024-11-01)

Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
by: Marta Valenza, et al.
Published: (2021-04-01)

NOX4-mediated astrocyte ferroptosis in Alzheimer’s disease
by: Yasenjiang Maimaiti, et al.
Published: (2024-07-01)

Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
by: Deepali Singh
Published: (2022-08-01)

The role of ADAM10 in astrocytes: Implications for Alzheimer’s disease
by: Richard J. Elsworthy, et al.
Published: (2022-11-01)

The role of astrocytes in Alzheimer's disease, A systematic review
by: Seyyed Mohammad Taghi Razavi-Toosi, et al.
Published: (2023-06-01)

Astrocytes’ Contribution to Adult Neurogenesis in Physiology and Alzheimer’s Disease
by: Frédéric Cassé, et al.
Published: (2018-11-01)

Pathological mechanisms and treatment progression of Alzheimer’s disease
by: Jingjing Zhang, et al.
Published: (2025-07-01)

Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
by: Som Singh, et al.
Published: (2022-07-01)